154 related articles for article (PubMed ID: 32871824)
1. Assessment of Systemic Inflammatory Response and Nutritional Markers in Patients With Trastuzumab-treated Unresectable Advanced Gastric Cancer.
Namikawa T; Maeda M; Yokota K; Tanioka N; Fukudome I; Iwabu J; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
In Vivo; 2020; 34(5):2851-2857. PubMed ID: 32871824
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer.
Namikawa T; Yokota K; Yamaguchi S; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kumon M; Kobayashi M; Hanazaki K
Oncology; 2020; 98(7):452-459. PubMed ID: 32182616
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer.
Namikawa T; Yokota K; Tanioka N; Fukudome I; Iwabu J; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2020 Nov; 50(11):1486-1495. PubMed ID: 32542414
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Langenbecks Arch Surg; 2022 Mar; 407(2):609-621. PubMed ID: 34652563
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Tamura T; Yatabe T; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Gastric Cancer; 2019 Jul; 22(4):684-691. PubMed ID: 30417313
[TBL] [Abstract][Full Text] [Related]
8. Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.
Hwang GY; Baek DW; Cho HJ; Lee SJ; Chae YS; Kang BW; Lee IH; Kim JG; Seo AN; Bae HI; Park KB; Park JY; Kwon OK; Lee SS; Chung HY
Anticancer Res; 2018 May; 38(5):3151-3156. PubMed ID: 29715156
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/Tipiracil.
Hashimoto I; Kano K; Onuma S; Suematsu H; Nagasawa S; Kanematsu K; Furusawa K; Hamaguchi T; Watanabe M; Hayashi K; Furuta M; Inokuchi Y; Machida N; Aoyama T; Yamada T; Rino Y; Ogata T; Oshima T
Anticancer Res; 2023 Apr; 43(4):1689-1697. PubMed ID: 36974783
[TBL] [Abstract][Full Text] [Related]
11. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.
Hannarici Z; Yılmaz A; Buyukbayram ME; Turhan A; Çağlar AA; Bilici M; Tekin SB
Future Oncol; 2023 Feb; 19(4):315-325. PubMed ID: 37125596
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
[TBL] [Abstract][Full Text] [Related]
13. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y
Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456
[TBL] [Abstract][Full Text] [Related]
15. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients.
Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2022 Nov; 52(11):1560-1567. PubMed ID: 35322296
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
Tokumaru S; Koizumi T; Sekino Y; Takeuchi N; Nakata S; Miyagawa Y; Kitazawa M; Muranaka F; Nakamura S; Koyama M; Yamamoto Y; Ehara T; Hondo N; Soejima Y
Oncology; 2021; 99(10):632-640. PubMed ID: 34280933
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer.
Shimizu T; Taniguchi K; Asakuma M; Tomioka A; Inoue Y; Komeda K; Hirokawa F; Uchiyama K
Anticancer Res; 2019 Apr; 39(4):2169-2176. PubMed ID: 30952764
[TBL] [Abstract][Full Text] [Related]
18. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
[TBL] [Abstract][Full Text] [Related]
20. A Novel Scoring System in Predicting Prognosis After Adjuvant FOLFOX Chemotherapy in Gastric Cancer.
Ge G; Li G; Zhang Z; Zhu Y; Wang W; Ren L; Li Z; Teng M
Cancer Biother Radiopharm; 2023 Aug; 38(6):388-395. PubMed ID: 35076265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
